AURA vs FDMT: stock comparison and AI forecast
Aura Biosciences, Inc. (AURA) and 4d Molecular Therapeutics, Inc. (FDMT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AURA Aura Biosciences, Inc.
- Price
- $6.24 -29.9% · 6M
- Market Cap
- $647M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
FDMT 4d Molecular Therapeutics, Inc.
- Price
- $11.95 +23.1% · 6M
- Market Cap
- $660M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- AURA and FDMT have similar market capitalizations ($647M and $660M).
- Over the last six months FDMT returned +23.1% and AURA -29.9%.
- FDMT carries 0.21 times debt per unit of equity, against 0.10 times for AURA.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AURA | FDMT |
|---|---|---|
| Market Cap | $647M | $660M |
| P/B Ratio | 2.05x | 1.62x |
| EPS | $-1.77 | $-3.49 |
| Book Value/Share | $3.04 | $7.38 |
| Revenue/Share | – | $1.67 |
| FCF/Share | $-1.00 | – |
Profitability & Margins
| Metric | AURA | FDMT |
|---|---|---|
| ROE | -41.6% | -44.0% |
| ROA | -37.6% | -36.4% |
| ROIC | -42.0% | -44.3% |
| Operating Margin | – | -214.2% |
| Net Margin | – | -194.7% |
| EBT Margin | – | -214.2% |
| Tax Rate | -0.1% | 0.0% |
Financial Health
| Metric | AURA | FDMT |
|---|---|---|
| Current Ratio | 16.82x | 8.03x |
| D/E Ratio | 0.10x | 0.21x |
| Financial Leverage | 1.10x | 1.21x |
| Working Capital | $309M | $335M |
Cash Flow
| Metric | AURA | FDMT |
|---|---|---|
| Operating Cash Flow | -$103M | -$156M |
| Free Cash Flow | -$103M | – |
| Capital Spending | -$340K | – |
Operational Efficiency
| Metric | AURA | FDMT |
|---|---|---|
| Asset Turnover | – | 0.19x |
| Fixed Assets Turnover | – | 7.4x |
Income Statement
| Metric | AURA | FDMT |
|---|---|---|
| Total Revenue | – | $92M |
| Operating Income | -$138M | -$197M |
| Net Income | -$131M | -$179M |
| R&D Expense | $103M | $240M |
Dividend & Shareholder Information
| Metric | AURA | FDMT |
|---|---|---|
| Shares Outstanding | 104M | 55M |
AURA vs FDMT: stock comparison and AI forecast
Which is bigger, AURA or FDMT?
AURA and FDMT have similar market capitalizations ($647M and $660M).
Which stock performed better over the last six months, AURA or FDMT?
Over the last six months FDMT returned +23.1% and AURA -29.9%.
Which one does Intratio's AI model rank higher, AURA or FDMT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.